Impact of age on the efficacy and safety of peficitinib (ASP015K) for the treatment of rheumatoid arthritis.

Yoshiya Tanaka Tsutomu Takeuchi Daisuke KatoYuichiro KanekoMusashi FukudaDaisuke Miyatake

Published in: Modern rheumatology (2021)

Peficitinib was efficacious in adult Asian RA patients of all ages. Age, but not estimated glomerular filtration rate, was associated with serious infections and herpes zoster-related disease, demonstrating the importance of an appropriate RA treatment strategy in older patients.

Keyphrases

rheumatoid arthritis
disease activity
end stage renal disease
ankylosing spondylitis
interstitial lung disease
patient reported